Companion Diagnostics (CDx) Development Services Market
Companion Diagnostics (CDx) Development
Services Market Scope: Industry Analysis, Market
Size, Growth, Trends Till 2031
Request Sample Report
Companion
Diagnostics (CDx) Development Services
Market Size and Growth
Companion Diagnostics (CDx) Development Services market research reports indicate a growing demand for personalized medicine and targeted therapies, driving the market growth. The global CDx market size is projected to reach $5.8 billion by 2027, with North America leading the market due to increased adoption of precision medicine.
Request Sample Report
Companies Covered
(Covid 19 Impact Covered)
◍ Geneuity-Clinical Research Services
◍ Interpace Biosciences
◍ Labcorp
◍ Quest Diagnostics
◍ Q² Solutions
◍ ResearchDx
◍ Almac Diagnostic Services
◍ Biocartis
◍ Cerba Research
◍ Eurofins Scientific
◍ MLM Medical Labs
◍ Qiagen
◍ BGI Genomics
◍ MEDx Translational Medicine
◍ Medical Biological Laboratories (MBL)
◍ Novogene
The companion diagnostics (CDx) development services market is highly competitive with key players like Labcorp, Quest Diagnostics, and Qiagen. These companies offer a range of services including biomarker discovery, assay development, and regulatory support. They use CDx to tailor treatments for patients and drive precision medicine initiatives.
- Labcorp: $11.8 billion
- Quest Diagnostics: $7.7 billion
- Qiagen: $1.5 billion
Request Sample Report
Market Segmentation
By Application
Infectious Diseases
Neurological Disorders
Request Sample Report
By Product
Feasibility Studies
Assay Development
Analytical Validation
Clinical Validation
Others
◍
◍
◍
◍
◍
◍
◍
Market Growth
Request Sample Report
$ X Billion USD
THANK YOU Email : sales@reportprime.com USA : +1 507 500 7209 Website : https://www.reportprime.com/ Request Sample Report Contact US Our Clients